GlassScriptPhysician profile
Brian C Abert
NPI 1134383094
$1,635.31
in general payments reported to CMS, 2019-2025
11 companies · $74.15 in 2025
The $74.15 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $167 · 2020: $90.71 · 2021: $183 · 2022: $318 · 2023: $394 · 2024: $408 · 2025: $74.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $876.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $727.30 | 2019-2024 | Acuvue |
| Bausch & Lomb Americas INC. | $315.46 | 2022-2025 | Infuse, Biotrue One Day, Alden Scleral Zenlens |
| Alcon Vision LLC | $139.76 | 2019-2025 | Precision 1, Precision7, Total30 |
| Oyster Point Pharma, INC. | $107.53 | 2022-2024 | Tyrvaya, Ryzumvi |
| Sun Pharmaceutical Industries INC. | $84.53 | 2020-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $80.92 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $67.11 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $59.88 | 2019-2021 | |
| Shire North American Group INC | $21.37 | 2019 | |
| Coopervision INC. | $17.61 | 2022 | |
| Lombart Brothers, INC. | $13.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Abert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.